発表論文一覧

試験№ 投稿誌 レファレンス 論文名 執筆者 
1 0401  Cancer Chemotherapy and Pharmacology  (2013) 72:1353-1359  Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non‑small cell lung cancer: LOGIK0401 Koichi Takayamaa
2 0402 Journal of Thoracic Oncology Volume3,Number10,
October 2008 1166-1171
A Phase II Trial of Gefitinib Monotherapy in Chemotherapy-Naı¨ve Patients of 75 Years or Older with Advanced Non-small Cell Lung Cancer  Noriyuki Ebi
3 0404 Journal of Infection and Chemotherapy (2010) 16:113-117 Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer in Japan Masaki Fujita
4 0501 General Thoracic and Cardiovascular Surgery vol.56 No.2 pp.68-73,February,
2008
Feasibility trial of adjuvant chemotherapy with paclitaxel and carboplatin after surgical resection in Japanese patients with non-small cell lung cancer: report of the Lung Oncology Group in Kyushu(LOGIK)
protocol0501
Richiro Maruyama
5 0601 Lung Cancer Volume 67,(February2010) 184-187 A Phase II Trial of Gefitinib Monotherapy in Chemotherapy-Naı¨ve Patients of 75 Years or Older with Advanced Non-small Cell Lung Cancer Noriyuki Ebi
6 0603  World Journal of Respirology  2016 March 28;6(1):42-48 Multicenter cooperative observational study of idiopathic pulmonary fibrosis with non-small cell lung cancer Noriyuki Ebi
7 0802  Anticancer Research 2016 Jun;36(6):2881-7 Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802). Kazuhiko
Yamada
8 0803   Japanese Journal of Clinical Oncology Advance Access April 18, 2013  Phase II Trial of Erlotinib for Japanese Patients With Previously Treated Non-Small-Cell Lung Cancer Harboring EGFR Mutations:Results of Lung Oncology Group in Kyushu (LOGiK0803) Kazuhiko Yamad
9 0901  International Journal of Clinical Oncology  (2014) 19:57-62  A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer:
A report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901
Riichiro Maruyama
 10 1003  Journal of Infection and Chemotherapy  22(2016)235-239  The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study Original Article Journal of Infection and Chemotherapy Masaki Fujita
 11 1004A   Thoracic Cancer 2017 Jan;8(1):40-45 Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Minoru Fukuda
 12 1004B   Thoracic Cancer  2016 Jul;7(4):467-72  Prospective Study of UGT1A1*27 Gene Polymorphism for Irinotecan Therapy in Patients with Lung Cancer Minoru Fukuda